Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20634209)

1.

Tubal ligation and the risk of ovarian cancer: review and meta-analysis.

Cibula D, Widschwendter M, Májek O, Dusek L.

Hum Reprod Update. 2011 Jan-Feb;17(1):55-67. doi: 10.1093/humupd/dmq030. Epub 2010 Jul 15. Review.

2.

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.

Liede A, Narod SA.

Hum Mutat. 2002 Dec;20(6):413-24. Review.

PMID:
12442265
3.

Modifiers of risk of hereditary breast and ovarian cancer.

Narod SA.

Nat Rev Cancer. 2002 Feb;2(2):113-23. Review.

PMID:
12635174
4.

Underlying mechanisms of ovarian cancer risk reduction after tubal ligation.

Cibula D, Widschwendter M, Zikan M, Dusek L.

Acta Obstet Gynecol Scand. 2011 Jun;90(6):559-63. doi: 10.1111/j.1600-0412.2011.01114.x. Epub 2011 Apr 15. Review.

PMID:
21355863
5.

Hereditary breast and ovarian cancers.

Carroll JC, Cremin C, Allanson J, Blaine SM, Dorman H, Gibbons CA, Grimshaw J, Honeywell C, Meschino WS, Permaul J, Wilson BJ.

Can Fam Physician. 2008 Dec;54(12):1691-2. Review. No abstract available.

6.

[Risk factors for the development of ovarian carcinoma].

Malinova M.

Akush Ginekol (Sofiia). 1999;38(1):57-60. Review. Bulgarian. No abstract available.

PMID:
11965725
7.

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention.

Søgaard M, Kjaer SK, Gayther S.

Acta Obstet Gynecol Scand. 2006;85(1):93-105. Review.

PMID:
16521688
8.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

Shulman LP.

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Review.

PMID:
20494261
9.

Management updates for women with a BRCA1 or BRCA2 mutation.

Nusbaum R, Isaacs C.

Mol Diagn Ther. 2007;11(3):133-44. Review.

PMID:
17570734
10.

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

Kauff ND, Barakat RR.

J Clin Oncol. 2007 Jul 10;25(20):2921-7. Review.

PMID:
17617523
11.

BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM.

Fam Cancer. 2006;5(1):15-20. Review.

PMID:
16528604
12.

Recent developments in ovarian cancer genetics.

Barnett GL, Friedrich CA.

Curr Opin Obstet Gynecol. 2004 Feb;16(1):79-85. Review.

PMID:
15128012
13.

Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer.

Narod SA, Boyd J.

Curr Opin Obstet Gynecol. 2002 Feb;14(1):19-26. Review.

PMID:
11801872
14.
15.

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.

Levy-Lahad E, Krieger M, Gottfeld O, Renbaum P, Klein G, Eisenberg S, Lahad A, Kaufman B, Catane R.

J Cell Biochem Suppl. 2000;34:13-8. Review.

PMID:
10762009
16.

[Prophylactic mastectomy in women at high risk for breast cancer: indications and options].

Scheufler O, Fritschen Uv.

Handchir Mikrochir Plast Chir. 2008 Aug;40(4):239-47. doi: 10.1055/s-2008-1038774. Epub 2008 Aug 20. Review. German.

PMID:
18716986
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk